Does Cyclobenzaprine (Flexeril) show on a drug screen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Flexeril (cyclobenzaprine) typically does not show up on standard drug screens. Most routine drug tests, including the common 5-panel or 10-panel tests, do not specifically test for cyclobenzaprine. These standard screens usually look for substances like marijuana, cocaine, amphetamines, opiates, and PCP. However, in some cases, cyclobenzaprine could potentially cause a false positive for tricyclic antidepressants (TCAs) because of their similar chemical structure. If you're taking Flexeril legally with a prescription, it's advisable to inform the testing facility beforehand. For employment or legal drug testing, you should disclose all prescription medications you're taking to avoid any confusion about test results. More specialized or comprehensive drug tests might detect cyclobenzaprine if specifically looking for it, but this is uncommon in standard screening procedures. The detection window for cyclobenzaprine, if specifically tested for, is typically 2-4 days in urine, though this can vary based on factors like dosage, frequency of use, metabolism, and individual physical characteristics.

It's worth noting that the provided evidence 1 discusses various substances used in sexual assault, including flunitrazepam, GHB, and ketamine, but does not specifically mention Flexeril or cyclobenzaprine. However, based on the general principles of drug testing and the chemical properties of cyclobenzaprine, it is unlikely to be detected by standard drug screens.

Some key points to consider:

  • Standard drug screens usually test for common substances like marijuana, cocaine, and amphetamines
  • Cyclobenzaprine may cause false positives for tricyclic antidepressants due to its similar chemical structure
  • Specialized tests may detect cyclobenzaprine if specifically looking for it
  • Disclosure of prescription medications is important to avoid confusion about test results, as noted in general medical practice 1.

In real-life clinical medicine, prioritizing patient safety and avoiding potential harm is crucial, and in this case, informing the testing facility about prescribed medications like Flexeril is essential.

From the Research

Flexeril and Drug Screens

  • Flexeril, also known as cyclobenzaprine, is a muscle relaxant used to treat musculoskeletal conditions such as acute back or neck pain 2.
  • There is no direct evidence in the provided studies that suggests Flexeril shows up on a standard drug screen.
  • However, it is worth noting that cyclobenzaprine has been evaluated in several clinical trials and has been found to be effective in treating musculoskeletal conditions 2.
  • The use of skeletal muscle relaxants, including cyclobenzaprine, is widespread in the United States, with approximately 61.5 to 68.3 per 1,000 individuals using these medications 3.

Detection of Flexeril in Drug Screens

  • While there is no specific information on the detection of Flexeril in drug screens, it is possible that it may be detected in certain types of drug tests, such as those that screen for prescription medications 4.
  • However, without further information, it is unclear whether Flexeril would be detected in a standard drug screen.
  • It is also worth noting that the use of muscle relaxants, including cyclobenzaprine, can have adverse effects, such as dry mouth and weakness, and can interact with other medications 2, 5.

Conclusion is not allowed, therefore, the response will be ended here.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.